Product Information
OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0563 per EA under NDC 16729032015. Its NADAC has been published 434 times since Mar 14, 2018.
FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729032015
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207662FDA Approved
4/24/2017
TE Code
AB
On Market Since
2/16/2018
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 434 times since Mar 14, 2018, and over the history we have for it it has declined 53.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0563 per EA |
|---|---|
| All-time high | $0.1389 (Mar 11, 2020) |
| All-time low | $0.0551 (Apr 19, 2023) |
| 52-week high | $0.0610 |
| 52-week low | $0.0563 |
| Median price | $0.0749 |
| Average price | $0.0811 |
| Largest weekly change | +44.4% (Jul 17, 2019) |
| Weeks tracked | 434 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
-2.4%
6M
-2.3%
1Y
-7.8%
3Y
-13.9%
5Y
-36.3%
All
-53.8%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Accord Healthcare Inc., is $0.0563 per EA (NDC 16729032015), effective Jul 1, 2026.
How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 53.8%. It has been tracked across 434 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?
Since Mar 14, 2018, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Apr 19, 2023) to a high of $0.1389 (Mar 11, 2020), with a median of $0.0749 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 5 MG TAB, is $0.0551 per EA — about 2% below OLMESARTAN MEDOXOMIL 5 MG TAB.
Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?
OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 16729032015) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.